LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 97 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $428,594 | -16.3% | 363,215 | 0.0% | 0.00% | – |
| Q2 2023 | $512,133 | +400.7% | 363,215 | +432.7% | 0.00% | – |
| Q1 2023 | $102,275 | +91.9% | 68,183 | +49.7% | 0.00% | – |
| Q4 2022 | $53,288 | +2.5% | 45,545 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | -27.8% | 45,545 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | -85.9% | 45,545 | -86.3% | 0.00% | – |
| Q1 2022 | $512,000 | -33.8% | 332,406 | +5.4% | 0.00% | – |
| Q4 2021 | $773,000 | -2.8% | 315,354 | 0.0% | 0.00% | – |
| Q3 2021 | $795,000 | -13.5% | 315,354 | -2.2% | 0.00% | – |
| Q2 2021 | $919,000 | +706.1% | 322,361 | +569.3% | 0.00% | – |
| Q1 2021 | $114,000 | -2.6% | 48,167 | -27.2% | 0.00% | – |
| Q4 2020 | $117,000 | +88.7% | 66,180 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | +6.9% | 66,180 | 0.0% | 0.00% | – |
| Q2 2020 | $58,000 | -70.1% | 66,180 | -71.7% | 0.00% | – |
| Q1 2020 | $194,000 | -6.7% | 233,687 | 0.0% | 0.00% | – |
| Q4 2019 | $208,000 | -9.6% | 233,687 | 0.0% | 0.00% | – |
| Q3 2019 | $230,000 | – | 233,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |